Outcome of breast cancer patients treated with chemotherapy during pregnancy compared with non-pregnant controls
- 17 May 2022
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 170, 54-63
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Prognosis of Women With Primary Breast Cancer Diagnosed During Pregnancy: Results From an International Collaborative StudyJournal of Clinical Oncology, 2013
- Case Control Study of Women Treated With Chemotherapy for Breast Cancer During Pregnancy as Compared With Nonpregnant Patients With Breast CancerThe Oncologist, 2013
- Trastuzumab administration during pregnancy: a systematic review and meta-analysisBreast Cancer Research and Treatment, 2012
- Anatomical, Physiological and Metabolic Changes with Gestational Age during Normal PregnancyClinical Pharmacokinetics, 2012
- Sequential Versus Concurrent Trastuzumab in Adjuvant Chemotherapy for Breast CancerJournal of Clinical Oncology, 2011
- An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational StudiesMultivariate Behavioral Research, 2011
- Presentation, Management and Outcome of 32 Patients with Pregnancy-Associated Breast Cancer: A Matched Controlled StudyThe Breast Journal, 2009
- Cause-Specific Survival for Women Diagnosed With Cancer During Pregnancy or Lactation: A Registry-Based Cohort StudyJournal of Clinical Oncology, 2009
- Estrogen Carcinogenesis in Breast CancerNew England Journal of Medicine, 2006
- Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast CancerNew England Journal of Medicine, 2005